John Mchale
John Mchale @johnmchale9JF

Performance
All

16.45%2026
2026
28.99%2025
2025
25.98%2024
2024
8.89%2023
2023
29.0%0%-29.0%
John Mchale
In July the S&P 500 fell 0.1% and our portfolio increased by 2.9%. For our portfolio two developments drove performance positively and negatively; there was a strong performance in European defence stocks and a major sell off in AI stocks which was exacerbated by distressed selling by leveraged... Show More
John Mchale
Shares in $GLUE (Monte Rosa Therapeutics Inc) are down 33% today as a $NVO (Novo-Nordisk A/S SPONS ADR) drug failed 😞 in a clinical trial to show sufficient medical benefit. $GLUE is <1% of our portfolio and we had recently sold a lot of our position with a 494% gain as a) the stock had run very... Show More
John Mchale
Shares in our portfolio holding $ALNY (Alnylam Pharmaceuticals Inc) are up 15% today as a potential competitor heart drug from $AZN.L (AstraZeneca) failed to meet its endpoint in clinical trials.
Not investment advice. The author may have financial interests in the mentioned instruments.
John Mchale
Shares in our defence industry holding $FCT.MI (Fincantieri S.p.A) are up over 10% today as it makes an earnings accretive acquisition in the marine vehicle construction sector. More broadly this is adding to a rally in the European defence sector which started at the beginning of July possibly related... Show More
undefined logo
FCT.MI
Fincantieri S.p.A
12.9550
-0.3050 (-2.30%)
John Mchale
In June the S&P 500 fell 1.3% and our portfolio by 4.6%. Two developments negatively affected our portfolio. Firstly the Mag 7 underperformed by 10% as there was a strong rotation away from what are seen as the big AI spenders to the chip makers which rallied strongly, and into industrials and... Show More
John Mchale
I’m not one for posting lots of economic factoids but sometimes one stands out. Investment in computer equipment contributed 0.9 percentage points of growth to annualised US real GDP in the first quarter, when total growth was 1.6%; ‘real’ meaning excluding the effect of inflation. The AI capex boom... Show More
John Mchale
In May the S&P 500 rose +4.7% narrowly driven by AI related names; narrow in the sense that a few memory chip names accounted for around half the market rise. Our portfolio was +4.3%. Taking a longer timeframe our portfolio is +13.9% over six months ahead of the S&P 500 +10.7%, and over 12 months... Show More
John Mchale
$STRL.US (Sterling Infrastructure Inc) was up 52% yesterday on a blow out Q1. It is a top ten holding in our portfolio. Sterling is playing a critical role in building the manufacturing production coming back to the US, the data infrastructure that enables artificial intelligence (AI) and other emerging... Show More
undefined logo
STRL.US
Sterling Infrastructure Inc
547.06
10.98 (2.05%)
John Mchale
In April the S&P 500 rebounded +9.9% and our portfolio was +8.8% lagging slightly due to our non US stocks. Year to date the S&P 500 is back in positive at +4.5% and our portfolio is +7.9%. Stocks that made a positive contribution in April were $GOOGL (Alphabet Inc Class A) +33.5% on strong... Show More
John Mchale
In March the S&P 500 ended -5.1% due to the economic fallout from the war in the Middle East. Our portfolio outperformed at -4.4%. It is encouraging that the portfolio can outperform both rising and falling markets which is because our portfolio is well diversified, is not dominated by one theme... Show More

About John Mchale
Ireland
Strategy: Growth

John has a strong reputation for delivering performance as a career investor at Fidelity.
Show Full Bio
6 Copiers
116 Followers